Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2014

01.11.2014 | Clinical trial

Understanding process-of-care delays in surgical treatment of breast cancer at a comprehensive cancer center

verfasst von: Mehra Golshan, Katya Losk, Sarah Kadish, Nancy U. Lin, Judith Hirshfield-Bartek, Linda Cutone, Yasuaki Sagara, Fatih Aydogan, Kristen Camuso, Saul N. Weingart, Craig Bunnell

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Few studies have examined care processes within providers’ and institutions’ control that expedite or delay care. The authors investigated the timeliness of breast cancer care at a comprehensive cancer center, focusing on factors influencing the time from initial consultation to first definitive surgery (FDS). The care of 1,461 women with breast cancer who underwent surgery at Dana-Farber/Brigham and Women’s Cancer Center from 2011 to 2013 was studied. The interval between consultation and FDS was calculated to identify variation in timeliness of care based on procedure, provider, and patients’ sociodemographic characteristics. Targets of 14 days for lumpectomy and mastectomy and 28 days from mastectomy with immediate reconstruction were set and used to define delay. Mean days between consultation and FDS was 21.6 (range 1–175, sd 15.8) for lumpectomy, 36.7 (5–230, 29.1) for mastectomy, and 37.5 (7–111, 16) for mastectomy with reconstruction. Patients under 40 were less likely to be delayed (OR = 0.56, 95 % CI = 0.33–0.94, p = 0.03). Patients undergoing mastectomy alone (OR = 2.64, 95 % CI = 1.80–3.89, p < 0.0001) and mastectomy with immediate reconstruction (OR = 1.34 95 % CI = 1.00–1.79, p = 0.05) were more likely to be delayed when compared to lumpectomy. Substantial variation in surgical timeliness was identified. This study provides insight into targets for improvement including better coordination with plastic surgery and streamlining pre-operative testing. Cancer centers may consider investing in efforts to measure and improve the timeliness of cancer care.
Literatur
1.
Zurück zum Zitat Richards MA, Smith P, Ramirez AJ, Fentiman IS, Rubens RD (1999) The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer 79(5–6):858–864PubMedCrossRefPubMedCentral Richards MA, Smith P, Ramirez AJ, Fentiman IS, Rubens RD (1999) The influence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer 79(5–6):858–864PubMedCrossRefPubMedCentral
2.
Zurück zum Zitat Smith EC, Ziogas A, Anton-Culver H (2013) Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity. JAMA Surg. 148(6):516–523PubMedCrossRef Smith EC, Ziogas A, Anton-Culver H (2013) Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity. JAMA Surg. 148(6):516–523PubMedCrossRef
3.
Zurück zum Zitat Desch CE, McNiff KK, Schneider EC et al (2008) American Society of Clinical Oncology/National Comprehensive Cancer Network quality measures. J Clin Oncol 26(21):3631–3637PubMedCrossRef Desch CE, McNiff KK, Schneider EC et al (2008) American Society of Clinical Oncology/National Comprehensive Cancer Network quality measures. J Clin Oncol 26(21):3631–3637PubMedCrossRef
4.
Zurück zum Zitat Institute of Medicine, Committee on Quality of Health Care in America (2011) Improving the 21st-century health care system-six aims for improvement. In: Crossing the Quality Chasm: a new health system for the 21st century. National Academy Press, Washington, DC, pp 53–54 Institute of Medicine, Committee on Quality of Health Care in America (2011) Improving the 21st-century health care system-six aims for improvement. In: Crossing the Quality Chasm: a new health system for the 21st century. National Academy Press, Washington, DC, pp 53–54
5.
Zurück zum Zitat Wright GP, Wong JH, Morgan JW, Roy-Chowdhury S, Kazanjian K, Lum S (2010) Time from diagnosis to surgical treatment of breast cancer: factors influencing delays in initiating treatment. Am Surg 76(10):1119–1122PubMed Wright GP, Wong JH, Morgan JW, Roy-Chowdhury S, Kazanjian K, Lum S (2010) Time from diagnosis to surgical treatment of breast cancer: factors influencing delays in initiating treatment. Am Surg 76(10):1119–1122PubMed
6.
Zurück zum Zitat Stuver SO, Zhu J, Simchowitz B, Hassett MJ, Shulman LN, Weingart SN (2011) Identifying women at risk of delayed breast cancer diagnosis. Jt Comm J Qual Patient Saf. 37:568–575PubMed Stuver SO, Zhu J, Simchowitz B, Hassett MJ, Shulman LN, Weingart SN (2011) Identifying women at risk of delayed breast cancer diagnosis. Jt Comm J Qual Patient Saf. 37:568–575PubMed
7.
Zurück zum Zitat Ramirez AG, Perez-Stable EJ, Talavera GA et al (2013 Dec) Time to definitive diagnosis of breast cancer in Latina and non-Hispanic white women: the six cities study. Springerplus. 2(1):84PubMedCrossRefPubMedCentral Ramirez AG, Perez-Stable EJ, Talavera GA et al (2013 Dec) Time to definitive diagnosis of breast cancer in Latina and non-Hispanic white women: the six cities study. Springerplus. 2(1):84PubMedCrossRefPubMedCentral
8.
Zurück zum Zitat Plotogea A, Chiarelli A, Mirea L, Prummel M et al (2013) Factors associated with wait times across the breast cancer treatment pathway in Ontario. Springerplus 2(388):1–9 Plotogea A, Chiarelli A, Mirea L, Prummel M et al (2013) Factors associated with wait times across the breast cancer treatment pathway in Ontario. Springerplus 2(388):1–9
9.
Zurück zum Zitat Arndt V, Sturmer T, Stegmaier C, Ziegler H, Dhom G, Brenner H (2002) Patient delay and stage of diagnosis among breast cancer patients in Germany—a population based study. Br J Cancer 86(7):1034–1040PubMedCrossRefPubMedCentral Arndt V, Sturmer T, Stegmaier C, Ziegler H, Dhom G, Brenner H (2002) Patient delay and stage of diagnosis among breast cancer patients in Germany—a population based study. Br J Cancer 86(7):1034–1040PubMedCrossRefPubMedCentral
10.
Zurück zum Zitat Afzelius P, Zedeler K, Sommer H, Mouridsen HT, Blichert-Toft M (1994) Patient’s and doctor’s delay in primary breast cancer. Acta Oncol. 33(4):345–351PubMedCrossRef Afzelius P, Zedeler K, Sommer H, Mouridsen HT, Blichert-Toft M (1994) Patient’s and doctor’s delay in primary breast cancer. Acta Oncol. 33(4):345–351PubMedCrossRef
11.
Zurück zum Zitat Landercasper J, Linebarger JH, Ellis RL et al (2010) A quality review of the timeliness of breast cancer diagnosis and treatment in an integrated breast center. J Am Coll Surg 210(4):449–455PubMedCrossRef Landercasper J, Linebarger JH, Ellis RL et al (2010) A quality review of the timeliness of breast cancer diagnosis and treatment in an integrated breast center. J Am Coll Surg 210(4):449–455PubMedCrossRef
12.
Zurück zum Zitat Sue GR, Lannin DR, Killelea B, Tsangaris T, Chagpar AB (2013) Does time to definitive treatment matter in patients with ductal carcinoma in situ? Am Surg 79(6):561–565PubMed Sue GR, Lannin DR, Killelea B, Tsangaris T, Chagpar AB (2013) Does time to definitive treatment matter in patients with ductal carcinoma in situ? Am Surg 79(6):561–565PubMed
13.
Zurück zum Zitat Stone MD, Norton S, Mendez JE, Hirsch E (2007) Positive impact of a breast-health training system on breast-care access and physician satisfaction. Am J Surg 194(4):482–487PubMedCrossRef Stone MD, Norton S, Mendez JE, Hirsch E (2007) Positive impact of a breast-health training system on breast-care access and physician satisfaction. Am J Surg 194(4):482–487PubMedCrossRef
14.
Zurück zum Zitat Hulvat M, Sandalow N, Rademaker A, Helenowski I, Hansen N (2010) Time from diagnosis to definitive operative treatment of operable breast cancer in the era of multimodal imaging. Surgery 148(4):746–751PubMedCrossRef Hulvat M, Sandalow N, Rademaker A, Helenowski I, Hansen N (2010) Time from diagnosis to definitive operative treatment of operable breast cancer in the era of multimodal imaging. Surgery 148(4):746–751PubMedCrossRef
15.
Zurück zum Zitat Tseng JF, Kronowitz SJ, Sun CC et al (2004) The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancer. Cancer 101(7):1514–1523PubMedCrossRef Tseng JF, Kronowitz SJ, Sun CC et al (2004) The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancer. Cancer 101(7):1514–1523PubMedCrossRef
Metadaten
Titel
Understanding process-of-care delays in surgical treatment of breast cancer at a comprehensive cancer center
verfasst von
Mehra Golshan
Katya Losk
Sarah Kadish
Nancy U. Lin
Judith Hirshfield-Bartek
Linda Cutone
Yasuaki Sagara
Fatih Aydogan
Kristen Camuso
Saul N. Weingart
Craig Bunnell
Publikationsdatum
01.11.2014
Verlag
Springer US
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2014
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-014-3124-2

Weitere Artikel der Ausgabe 1/2014

Breast Cancer Research and Treatment 1/2014 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.